
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Cannabidiol
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Endosane Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Endosane is focused on preclinical studies to evaluate the brain delivery characteristics of sol-gel technology and whether pharmacologically relevant concentrations of Cannabidiol can be achieved with this technology.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
September 18, 2023
Lead Product(s) : Cannabidiol
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Endosane Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Cannabidiol
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Recipient : Veristat
Deal Size : Undisclosed
Deal Type : Agreement
PreveCeutical Prepares for Clinical Trials for its Sol-Gel COVID-19 Program
Details : Under the terms of the consulting agreement, Veristat will provide services to design and develop PreveCeutical COVID-19 Sol-Gel clinical program and write the required protocol.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
August 04, 2020
Lead Product(s) : Cannabidiol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Recipient : Veristat
Deal Size : Undisclosed
Deal Type : Agreement

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The company has identified a promising modified delivery vector ready for possible pre-clinical experiments based on stable siRNA (small interfering ribonucleic acid) incorporation within the delivery vehicle.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 15, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
